129 related articles for article (PubMed ID: 25899145)
21. Platelet-derived growth factors in the developing avian heart and maturating coronary vasculature.
Van Den Akker NM; Lie-Venema H; Maas S; Eralp I; DeRuiter MC; Poelmann RE; Gittenberger-De Groot AC
Dev Dyn; 2005 Aug; 233(4):1579-88. PubMed ID: 15973731
[TBL] [Abstract][Full Text] [Related]
22. [Expression and significance of platelet derived growth factor and its receptor in liver tissues of patients with liver fibrosis].
Yuan N; Wang P; Wang X; Wang Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):58-60. PubMed ID: 11856507
[TBL] [Abstract][Full Text] [Related]
23. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
24. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability.
Zhang J; Cao R; Zhang Y; Jia T; Cao Y; Wahlberg E
FASEB J; 2009 Jan; 23(1):153-63. PubMed ID: 18827023
[TBL] [Abstract][Full Text] [Related]
25. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
27. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
28. Dietary GD3 ganglioside reduces the incidence and severity of necrotizing enterocolitis by sustaining regulatory immune responses.
Xu J; Anderson V; Schwarz SM
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):550-6. PubMed ID: 23783008
[TBL] [Abstract][Full Text] [Related]
29. Heat shock pretreatment reduces intestinal injury in a neonatal rat model of early necrotizing enterocolitis.
Kim EK; Lee KY; Lee HJ; Lee JA; Choi CW; Kim HS; Kim BI; Choi JH
Neonatology; 2013; 103(1):1-6. PubMed ID: 22948204
[TBL] [Abstract][Full Text] [Related]
30. Oligohydramnios decreases platelet-derived growth factor expression in fetal rat lungs.
Chen CM; Wang LF; Chou HC; Lang YD
Neonatology; 2007; 92(3):187-93. PubMed ID: 17519529
[TBL] [Abstract][Full Text] [Related]
31. Bile acids induce ileal damage during experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Saunders TA; Dvorak K; Clark JA; Doelle SM; Ballatori N; Dvorak B
Gastroenterology; 2006 Feb; 130(2):359-72. PubMed ID: 16472592
[TBL] [Abstract][Full Text] [Related]
32. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
33. Glutamine downregulates TLR-2 and TLR-4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis.
Zhou W; Li W; Zheng XH; Rong X; Huang LG
J Pediatr Surg; 2014 Jul; 49(7):1057-63. PubMed ID: 24952788
[TBL] [Abstract][Full Text] [Related]
34. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
35. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
[TBL] [Abstract][Full Text] [Related]
36. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod.
Zamora R; Grishin A; Wong C; Boyle P; Wang J; Hackam D; Upperman JS; Tracey KJ; Ford HR
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G643-52. PubMed ID: 15947118
[TBL] [Abstract][Full Text] [Related]
37. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
Liegl B; Leithner A; Bauernhofer T; Windhager R; Guelly C; Regauer S; Beham A
Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
[TBL] [Abstract][Full Text] [Related]
39. Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia.
Renner O; Tsimpas A; Kostin S; Valable S; Petit E; Schaper W; Marti HH
Brain Res Mol Brain Res; 2003 May; 113(1-2):44-51. PubMed ID: 12750005
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
